Researchers have created a prototype system that uses a mathematical model to predict – and a portable inkjet technology to produce – precise medication dosages tailored for specific patients, an advance in personalized medicine that could improve drug effectiveness and reduce adverse reactions.
Drug makers now manufacture tablets based on clinical studies that determine the average recommended dose. Often this average falls outside of the optimal dose for a particular patient, but there is no way to precisely adjust the dosage except by trial and error.
“Pharmaceutical companies make one or two or three dosage levels, so people try breaking tablets in half and other methods to get to the right dosage,” said Gintaras “Rex” Reklaitis, Purdue University’s Burton and Kathryn Gedge Distinguished Professor of Chemical Engineering.
Delivering a more precise dosage improves the effectiveness of drugs and reduces potential side effects.
“Many drugs have a minimum effective level, so you need to meet that, and many of them have a toxic level,” he said. “The closer you get to it the more side effects there are.”
The new approach uses a combination of data and mathematics to determine the precise dosage. Two or three blood samples are drawn from the patient after a small quantity of the drug is administered. Data from those samples are combined with information from clinical studies of larger numbers of patients, and mathematical models are used to determine the proper dose for a particular patient.
Then, a portable technology dissolves or melts the drugs with polymers and uses “drop-on-demand” inkjet printing technology to deposit exact quantities onto tablets or films. Melting medications requires more careful control than simply dissolving them. However, melting could offer benefits over solutions, Reklaitis said. Many of the newest drugs are poorly soluble in the bloodstream. Precisely controlling temperatures during the melting procedure could allow drug makers to control the drug properties and increase solubility.
“We envision that in its final form the printing will be done in an automated fashion. The pharmacist could key in the dose, the machine prints 20 tablets, and off you go,” said Reklaitis, who is working with a team of researchers led by Arun Giridhar, an associate research scientist in the School of Chemical Engineering, and Poching DeLaurentis, a research scientist in Purdue’s Oncological Sciences Center.
The team has built a prototype and is working toward commercialization of a device, which is about the size of a large laser printer. Recent research findings are detailed in papers published this year in the Journal of Pharmaceutical Sciences and the journal Pharmacotherapy.
The dosage-prediction research was pioneered by Gary E. Blau, a visiting professor in the School of Chemical Engineering, who died earlier this year. It has been funded by the National Science Foundation.
One of the research papers focuses on the mathematical method for predicting a patient’s dose while the other describes the drop-on-demand technology applied to solvent-based systems, work that has been supported under the NSF Engineering Research Centers (ERC) program.
“If we say the patient needs 23 milligrams every eight hours, there is no 23-milligram tablet on the market,” Giridhar said. “I can make a 23-milligram dose, but to make something that small and that precise is challenging to do with powders. It is much easier to dissolve or melt the drug formulation. Both are viable technologies.”
In personalized medicine, physicians use diagnostic methods to determine the precise therapy for each patient.
“We are saying that’s great, but you are still faced with the problem of how to administer the drug,” said Reklaitis, deputy director of an NSF ERC formed in 2006 to improve the way pharmaceuticals, foods and agricultural products are developed and manufactured.
“In the past, we haven’t had the mathematical tools to do this.”
DeLaurentis focuses on the mathematical and statistical methods required to determine the drug dosage, building on research initiated by Blau, Reklaitis and former postdoctoral research associate Jose M. Lainez. Giridhar is leading research to develop the portable system with doctoral student Elcin Icten. The work on the printing device also is supported by the Indiana Next Generation Manufacturing Competitiveness Center – IN-MaC – led by Purdue to attract, retain and grow high-value manufacturing industries in the state.
Researchers are involved in clinical studies to learn how effective the procedure is.
The same strategy – using prediction methods coupled with limited blood sampling – could enable health care professionals to monitor a drug’s effectiveness over time and adjust the dosage for the patient as needed.
The Latest on: Precise drug dosages
The Latest on: Biomechanics
via Google News
The Latest on: Precise drug dosages
- Gofire Launches Patented, Metered-dose Inhaler to Vaporization Market Seeking Safe, Accurate Dose Controlon November 14, 2019 at 4:40 pm
Together, the Gofire Inhaler and Gofire App create a “smart health ecosystem” enabling the precise dosage and replicable experience patients and physicians have been seeking from alternative medicines ...
- GDR 30 Years On: The Day In 1989 The Berlin Wall Came Tumbling Down On Doping Regimeon November 9, 2019 at 1:10 am
Thankfully, there was just too much to shred, too much to hide, too many notes to wipe from the slate of history. They included scribblings of the precise dosages of steroids and other ...
- Impact Story: Finding a Better Test for Predicting the Risk Drugs Pose to the Hearton October 28, 2019 at 7:15 am
FDA research has laid the groundwork for replacing the thorough QT (TQT) study, a costly clinical trial required to determine whether new drugs cause abnormal heart rhythms (arrhythmias), with a more ...
- New drug-delivery technology promises efficient, targeted cancer treatmenton October 22, 2019 at 12:22 pm
A precise and non-toxic treatment that targets lung cancer cells at the nanoscale ... The researchers' dual-drug approach enabled the use of a lower dose of the cancer drugs than using a single drug, ...
- New drug-delivery technology promises efficient, targeted cancer treatmenton October 22, 2019 at 11:44 am
A precise and non-toxic treatment that targets lung cancer ... The researchers' dual-drug approach enabled the use of a lower dose of the cancer drugs than using a single drug, leading to effective ...
- California company Dosist dials up precise delivery system with $1 cannabis tabletson October 8, 2019 at 8:50 am
The company has just released the Dose Dial, a new product that takes the uncertainty out of using cannabis by guaranteeing that each of its peppermint-flavoured tablet holds precise amount of the ...
- Approaching risk as if life depended upon iton September 25, 2019 at 5:23 pm
From mobile healthcare apps that track patients’ symptoms in real time to precise drug dosages for neonatal patients, emerging technologies present limitless potential for life sciences and healthcare ...
- Rapid Dose Therapeutics Completes Quickstrip™ Equipment Installation at Aphria Inc.on September 10, 2019 at 4:12 am
we believe the QuickStrip™ will help ease concerns surrounding consumption by providing a smoke-free product that delivers a consistent and precise dosage,” added Simon. About Rapid Dose Therapeutics ...
- Syqe Medical Receives Regulatory Approval to Release World's First Drug Delivery Device for Precise Dosing of Cannabison June 20, 2019 at 6:12 am
This launch marks the beginning of a new chapter in pain treatment, one in which physicians can confidently prescribe precise dosages of cannabis, and patients can reap the rewards, effectively and ...
via Bing News